AAPS PharmSciTech

, Volume 9, Issue 2, pp 480–485 | Cite as

Floating Osmotic Drug Delivery System of Ranitidine Hydrochloride: Development and Evaluation—A Technical Note

Brief/Technical Note

Key words

floating osmotic delivery ranitidine hydrochloride zero-order delivery 

References

  1. 1.
    N. Rouge, P. Buri, and E. Doelker. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. 136:117–139 (1996).CrossRefGoogle Scholar
  2. 2.
    J. T. Fell, L. Whitehead, and H. Collet. Prolonged gastric retention using floating dosage forms. Pharm. Technol. 24:82–90 (2000).Google Scholar
  3. 3.
    J. T. Fell. Delivery systems for targeting to specific sites in the gastrointestinal tract. J. Pharm. Pharmacol. 51Suppl:41 (1999).Google Scholar
  4. 4.
    R. K. Verma, B. Mishra, and S. Garg. Osmotically controlled oral drug delivery. Drug Dev. Ind. Pharm. 26:695–708 (2000).PubMedCrossRefGoogle Scholar
  5. 5.
    P. Kumar, S. Singh, P. S. Rajinikanth, and B. Mishra. An overview of osmotic pressure controlled release formulation. J. Pharm. Res. 5:34–45 (2006).Google Scholar
  6. 6.
    S. Grant. Ranitidine: an updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer and other allied diseases. Drugs. 37:801–870 (1989).PubMedCrossRefGoogle Scholar
  7. 7.
    A. W. Basit, and L. F. Lacey. Colonic metabolism of ranitidine: implications for its delivery and absorption. Int. J. Pharm. 227:157–165 (2001).PubMedCrossRefGoogle Scholar
  8. 8.
    N. Sinchaipanid, S. Pongwai, P. Limsuwan, and A. Mitrevej. Design of salbutamol EOP tablets from pharmacokinetic parameters. Pharm. Dev. Tech. 8:135–142 (2003).CrossRefGoogle Scholar
  9. 9.
    R. Regenthal, M. Krueger, C. Koeppel, and R. Preiss. Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs. J. Clin. Monit. 15:529–544 (1999).CrossRefGoogle Scholar
  10. 10.
    N. Ozdemir, and J. Sahin. Design of a controlled release osmotic pump system of ibuprofen. Int. J. Pharm. 158:91–97 (1997).CrossRefGoogle Scholar
  11. 11.
    Y. S. R. Krishnaiaha, V. Satyanarayana, P. R. Bhaskar, and R. S. Karthikeyan. Studies on development of oral colon targeted drug delivery systems for metronidazole in treatment of amoebiasis. Int. J. Pharm. 236:43–55 (2002).CrossRefGoogle Scholar
  12. 12.
    R. K. Verma, and S. Garg. Development and evaluation of osmotically controlled oral drug delivery systems of glipizide. Eur. J. Phar. Biopharm. 57:513–525 (2004).CrossRefGoogle Scholar
  13. 13.
    A. K. Srivastava, D. Wadhwa, D. Ridhurkar, and B. Mishra. Oral sustained delivery of Atenolol from floating matrix tablets—formulation and in-vitro evaluation. Drug. Dev. Ind. Pharm. 31:367–374 (2005).PubMedGoogle Scholar
  14. 14.
    F. Theeuwes. Elementary osmotic pump. J. Pharm. Sci. 64:1987–1991 (1975).PubMedCrossRefGoogle Scholar
  15. 15.
    D. Prabakaran, P. Singh, P. Kanaujia, and S. P. Vyas. Effect of hydrophilic polymers on the release of Diltiazem hydrochloride from elementary osmotic pump. Int. J. Pharm. 259:173–179 (2003).PubMedCrossRefGoogle Scholar
  16. 16.
    D. A. Alderman. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int. J. Pharm. Technol. Prod. Manuf. 5:1–9 (1984).Google Scholar
  17. 17.
    M. Chavanpatil, P. Jain, S. Chaudhari, R. Shear, and P. Vavia. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. Int. J. Pharm. 304:178–184 (2005).PubMedCrossRefGoogle Scholar
  18. 18.
    P. Costa, and J. M. S. Lobo. Modeling and comparison dissolution profiles. Int. J. Pharm. 13:123–133 (2001).Google Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2008

Authors and Affiliations

  • Pramod Kumar
    • 1
  • Sanjay Singh
    • 1
  • Brahmeshwar Mishra
    • 1
  1. 1.Department of Pharmaceutics, Institute of TechnologyBanaras Hindu UniversityVaranasiIndia

Personalised recommendations